MICHAEL STEVENSON: Open Payments
NPI 1639430853 · SMITHFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 84 payments from 24 companies in 2025. Trend: 2023 $1,289 · 2024 $1,294 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $320 |
| PFIZER INC. | 10 | $208 |
| AstraZeneca Pharmaceuticals LP | 3 | $141 |
| Lundbeck LLC | 7 | $118 |
| Novo Nordisk Inc | 6 | $115 |
| Lilly USA, LLC | 8 | $112 |
| GlaxoSmithKline, LLC. | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 4 | $94 |
| Boston Scientific Corporation | 3 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
Products named: REXULTI, NURTEC ODT, UBRELVY, FARXIGA, TRELEGY ELLIPTA, QULIPTA, WATCHMAN FLX, VRAYLAR.
Industry payments across VA — which companies pay providers there.
